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Abstract
 
Conserved differences between the transmembrane and cytoplasmic domains of membrane im-
munoglobulin (Ig)M and IgG may alter the function of antigen receptors on naive versus
memory B cells. Here, we compare the ability of these domains to signal B cell allelic exclusion
and maturation in transgenic mice. A lysozyme-binding antibody was expressed in parallel sets
of mice as IgM, IgG1, or a chimeric receptor with IgM extracellular domains and transmem-
brane/cytoplasmic domains of IgG1. Like IgM, the IgG1 or chimeric IgM/G receptors trig-
 
gered heavy chain allelic exclusion and supported development of mature CD21
 
1
 
 B cells.
Many of the IgG or IgM/G B cells became CD21
 
high
 
 and downregulated their IgG and IgM/G
receptors spontaneously, resembling memory B cells and B cells with mutations that exaggerate
B cell antigen receptor signaling. Unlike IgM-transgenic mice, “edited” B cells that carry non–
hen egg lysozyme binding receptors preferentially accumulated in IgG and IgM/G mice. This
was most extreme in lines with the highest transgene copy number and diminished in variant
offspring with fewer copies. The sensitivity of B cell maturation to transgene copy number
conferred by the IgG transmembrane and cytoplasmic domains may explain the diverse pheno-
types found in other IgG-transgenic mouse strains and may reflect exaggerated signaling.
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Introduction
 
B cell antigen receptors (BCRs)
 
1
 
 undergo stereotypic
changes in their constant regions during development of
each B lymphocyte. B cells of the preimmune repertoire
express first IgM and then IgM and IgD receptors of the
same antigen specificity (1–4), whereas memory B cells ei-
ther express IgM or switch to downstream isotypes such as
IgG, IgA, or IgE (5–7). The constant regions of these iso-
types differ markedly not only in the C
 
H1
 
, hinge, and Fc
domains but also in the membrane-proximal spacer, trans-
membrane, and cytoplasmic segments required for cell sur-
face expression. Interestingly, the latter domains are highly
conserved within isotypes and between species (8–15). For
example, the different IgG subtypes have an almost identi-
cal amino acid sequence in their extracellular spacer, trans-
membrane, and cytoplasmic regions in mice and humans,
whereas they are more divergent in the hinge and Fc do-
mains (16–18). In addition, the cytoplasmic tails of IgM
and IgD receptors consist of only three amino acids (KVK),
whereas receptors expressed uniquely on memory cells
have more extended cytoplasmic tails of either 28 (IgG,
IgE) or 14 (IgA) evolutionarily conserved amino acids (17–
19). The highly conserved and isotype-specific nature of
the membrane proximal regions suggests stage-specific sig-
naling or intracellular trafficking functions attributed to the
different isotypes (17–20). In support of this notion, IgG1
or IgE memory B cell production and antibody responses
in mice are diminished by mutations that truncate the cyto-
plasmic tail of IgG1 or IgE, respectively (21, 22).
Comparing the function of naive and memory BCR iso-
types in vivo is normally complicated by differences in
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Abbreviations used in this paper:
 
 BCR, B cell antigen receptor; Hc,
heavy chain; HEL, hen egg lysozyme; Lc, light chain; RAG, recombinase
activating gene; SHP, Src homology 2 domain–containing protein ty-
rosine phosphatase; Tg, transgene. 
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BCR affinity, specificity, B cell location, and activation
state that are also brought about by immunization. Any dif-
ference between the behavior of naive IgM-bearing B cells
and primed IgG-bearing cells would be difficult to ascribe
to the BCR isotype or to priming. These variables can be
separated, in principle, by constructing transgenic mice in
which IgG or another downstream isotype is constitutively
expressed as the sole BCR on B cells independent of any
need for immunization. A number of research groups have
constructed IgG-transgenic mice with different V
 
H
 
/V
 
L
 
specificities, but these have yielded variable results and con-
clusions (23–30). In some studies, the 
 
g
 
 heavy chain (Hc)
signaled allelic exclusion, at least to the extent that endoge-
nous IgM expression was inhibited in the bone marrow
(27, 28, 30, 31), whereas in other studies allelic exclusion
was not apparent (23, 24). Of the mice that failed allelic ex-
clusion, the presence of membrane IgG was either not di-
rectly assessed (23) or very low (24), suggesting that the
failure of allelic exclusion in these mice may be a reflection
of little or no surface IgG expression. The polyadenylation
sites of the M2 exon for C
 
g
 
1, C
 
g
 
2b, and C
 
g
 
3 have not yet
been precisely located by DNA sequencing, and failure to
achieve surface IgG expression in some experiments may
have been due to lack of the pA sites in the DNA con-
structs (24) or lack of inclusion of membrane exons due to
their deletion during the integration process (23).
Another variable finding in IgG-transgenic mice has
concerned the capacity of IgG to substitute for IgM in sup-
porting B cell maturation from immature B cells in the
bone marrow through to mature recirculating cells in the
spleen and lymph nodes. The most detailed studies to date
are those of Roth and coworkers (27, 29) in multiple lines
of transgenic mice carrying the IgG2b Hc for an anti-
 
Pseudomonas
 
 antibody. With the exception of one unusual
variant line, the transgenic IgG receptor did not support
maturation, and the majority of spleen and lymph node B
cells that developed expressed low levels of IgG and bore
endogenous IgM and IgD receptors (27–29). Similarly,
very few IgG only–bearing cells were found in the periph-
ery of mice constructed by Yamamura et al., Tsao et al.,
Offen et al., and Battegay et al. (23–25, 30). By contrast,
mature B cells expressing exclusively IgG were found in
large numbers in one transgenic line carrying an anti-
 
Pseudomonas
 
 IgG2b Hc (28, 29), and modest numbers were
found in transgenic mice carrying an antibacterial phosphor-
ylcholine IgG2b transgene (Tg; reference 28). The reason
for these differences is unclear, leaving unresolved the ex-
tent to which IgG may differ from IgM or IgD in its capac-
ity to signal B cell maturation in the preimmune repertoire.
To compare the in vivo function of IgG1 and IgM as an-
tigen receptors on B cells directly, independent of any dif-
ferences in V
 
H
 
/V
 
L
 
 specificity, microenvironment, state of
priming, or antigenic experience, we have generated trans-
genic mice carrying Hc and Lc (light chain) genes encoding
a well characterized lysozyme-binding antibody (32, 33) of
IgG1 isotype. These mice could then be directly compared
with previously established IgM-transgenic mice carrying
the same antilysozyme V regions. To examine the role of
 
the conserved IgG transmembrane/cytoplasmic tail region
in isolation, an additional set of transgenic mice was made
expressing an IgM/G chimeric receptor comprising the
IgM C
 
H1
 
 and Fc regions and the IgG1 extracellular spacer,
transmembrane, and cytoplasmic domains. We find that the
IgG1 and IgM/G receptors can substitute for IgM in sup-
porting generation of large numbers of recirculating B cells
in spleen and lymph nodes. Unlike IgM- or IgD-transgenic
mice, the numbers of mature B cells expressing transgenic
BCRs in IgG1 and IgM/G mice is very sensitive to Tg
copy number. Few are present in blood, spleen, or lymph
node in higher copy number lines, where they are replaced
by B cells with different BCRs. The characteristics of B cell
development in these animals are most consistent with en-
hanced signaling by IgG BCRs conferred in part by the
unique membrane/tail domains.
 
Materials and Methods
 
Gene Constructs.
 
IgM-transgenic mice were produced previ-
ously by coinjecting Hc (V
 
H
 
10–
 
m
 
) and Lc (V
 
k
 
10–C
 
k
 
) Ig gene
constructs into the germline of C57BL/6 (Hc b-allotype, IgH
 
b
 
)
mice (34, 35). These constructs together encode IgM (Hc a-allo-
type, IgH
 
a
 
) carrying the antigen binding site of the high-affinity
(1.5 
 
3
 
 10
 
9
 
 M
 
2
 
1
 
) anti–hen egg lysozyme (HEL) mAb HyHEL10
(32, 33). The IgG1 gene construct was produced from a plasmid,
pTB6, which contained a genomic clone of the productive H lo-
cus from hybridoma HyHEL10, carrying the promoter, L–VDJ
exons, the 
 
m
 
/
 
g
 
1 switch recombination region, the 
 
g
 
1 constant
domains, and the first 
 
g
 
1 membrane exon (from Drs. T. Lavoie
and S. Smith-Gill, National Institutes of Health, Bethesda, MD).
The insert from pTB6 was cloned into plasmid pSVG-
 
g
 
M2 con-
taining the 
 
g
 
1 M2 exon plus 
 
z
 
2.5 kb of downstream sequence,
derived from 
 
l
 
 phage clone G1.2 (36). The V
 
k
 
10–C
 
k
 
 gene con-
struct was described previously (34).
The chimeric IgM/G Hc gene construct was generated by
“sticky feet–directed mutagenesis” (37). In brief, oligonucleotide
primers were synthesized in which the 5
 
9
 
 30 nucleotides corre-
sponded to the IgM nucleotides flanking the IgG1 insertion site
(uppercase letters), and the 3
 
9
 
 15 nucleotides corresponded with
the DNA flanking the IgG1 insertion sequences (lowercase let-
ters). The primers used were as follows: forward, 5
 
9
 
-GACCCT-
CCCTCTCTGTGTCCCTTCATAGAGgggctgcaactggacgag-3
 
9
 
;
reverse: 5
 
9
 
-GTCTCTGCTGTCCTTCCATGCTGAGAGctagg-
gcgcttgcccaatc-3
 
9
 
. After mutagenesis, a 
 
KpnI
 
–
 
SpeI
 
 fragment con-
taining the modified membrane exons was inserted into a pSVG
plasmid containing the IgM constant domain exons and HyHEL10
V region (35).
 
Transgenic Lines.
 
For microinjection, IgG1 and IgM/G gene
constructs were separated from vector sequences by digestion with
ClaI and NotI restriction enzymes and purified as described (34).
IgG1 (V
 
H
 
10–
 
g
 
 
 
1
 
 V
 
k
 
10–C
 
k
 
) and IgM/G (V
 
H
 
10–
 
mg
 
 
 
1
 
 V
 
k
 
10–C
 
k
 
)
founder Ig-transgenic mice were generated after microinjection of
embryos from (C57BL/6 
 
3
 
 CBA/J)F1 females with an equimolar
mixture of Hc and Lc constructs as described (34, 38). Screening
for founder Ig-transgenic mice and initial progeny was performed
by Southern blot analysis of tail DNA (34, 38). Routine screening
for transgenic Hc was done using PCR (reference 39; for details
see http://jcsmr.anu.edu.au/group_pages/mgc/). Transgenic lines
were maintained by backcrossing to C57BL/6J. In addition, two
Ig-transgenic lines, IgM/G (
 
mg
 
2) and IgG1 (
 
gg
 
4), were crossed 
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with recombinase activating gene (RAG-2)
 
2
 
/
 
2
 
 mice originally
provided by Dr. Fred Alt (Children’s Hospital, Boston, MA).
Generation of IgM-transgenic line was described previously (35).
For Hc copy number estimates, Southern blots of XbaI-digested
tail DNA were probed with a 912 bp 
 
HindIII
 
–
 
XbaI
 
 fragment from
the germline JH4 region. The JH probe identified a 3.6-kb frag-
ment derived from unrearranged endogenous Hc genes in all mice
and a single 3.0-kb fragment from the rearranged Hc Tg. For Lc
copy number estimates, the same XbaI-digested Southern blots
were reprobed with a 650-bp 
 
AvaI
 
–
 
XbaI
 
 fragment from the germ-
line J
 
k
 
4 region, revealing a 3.8-kb endogenous 
 
k
 
 fragment and a
2.6-kb Tg 
 
k
 
 band. Autoradiographs in the linear range of the film
were scanned on a Molecular Dynamics scanning densitometer,
areas under the curves were measured, and copy numbers were
expressed by assigning the endogenous signals a copy number of
two. For visualizing loss of array copies, Southern blots of SacI-
digested tail DNA were probed with a 912-bp 
 
HindIII–XbaI
 
 frag-
ment from the germline JH4 region. Because there is no Sac1 site
5
 
9
 
 to the JH probe within the microinjected Hc construct, this re-
sults in an 11-kb fragment generated by head-to-tail junction frag-
ments with upstream Hc copies in tandem arrays and a unique
fragment at the 5
 
9
 
 end of the array.
 
FACS
 
®
 
 Analysis.
 
The following antibodies were used (speci-
ficities in parentheses): RS3.1 (IgM
 
a
 
; reference 40); AMS-9.1
(IgD
 
a
 
; reference 41); AFS122.2 (IgD
 
b
 
); RA3-6B2 (B220; refer-
ence 42); HyHEL9 (HEL; reference 43); S7 (CD43); M1/69
(HSA); and 7G6 (CR1/2; reference 44). Spleen and bone marrow
cells were prepared and stained for FACS
 
®
 
 analysis as previously
indicated (34). HEL binding was detected with 200 ng/ml of HEL
followed by HyHEL9–tricolor conjugate. Analysis was performed
 
on a FACScan™
 
 
 
flow cytometer (Becton Dickinson) with FACS
 
®
 
desk software (Beckman Center Shared FACS
 
®
 
 Facility).
 
Results
 
Constructs and Transgenic Mice.
 
To allow direct com-
parison between the function of IgM and IgG1 antigen re-
ceptors, we modified a rearranged Hc gene construct that
was used previously to produce IgM Hc- and Lc-trans-
genic mice (35). The original 
 
m
 
 construct and the two
modified Hc constructs used in this study, 
 
g
 
1 and 
 
m
 
/
 
g
 
1,
employed identical VDJH variable region elements derived
from the original lysozyme-binding hybridoma, HyHEL10
(32). The chimeric 
 
m
 
/
 
g
 
1 construct was generated by selec-
tively replacing the 
 
m
 
 membrane coding elements with 
 
g
 
1
membrane coding sequences using sticky feet–directed
mutagenesis to preserve the 
 
m
 
M1 splice acceptor and the
 
m
 
M2 3
 
9
 
 untranslated regions and poly A signals. As illus-
trated in Fig. 1, the extracellular C
 
H1
 
–C
 
H4
 
 portion of the
 
mg
 
1 Hc was identical to the IgM extracellular region,
thereby enabling use of identical reagents for analysis and
allowing any phenotypic differences to be directly attrib-
uted to the 
 
g
 
1 membrane-coding segment. The IgG1 Hc
construct was derived from genomic DNA of the original
lysozyme-binding HyHEL10 IgG1
 
1
 
 hybridoma, which
had retained the 
 
m
 
/
 
g
 
 switch regions (Fig. 1 C). Inclusion
of the switch region has been reported to be essential for
Figure 1. Schematic representa-
tion of Hc constructs used to gener-
ate antilysozyme IgM- (A), IgG1-
(B), and IgM/G-transgenic (C)
mice. Wide boxes indicate protein
coding regions, medium boxes indi-
cate untranslated regions or switch
recombination sequences, and filled
oval represents the m intron enhancer.
Unfilled boxes indicate m-specific se-
quences, black boxes indicate g1 se-
quences, and gray boxes are shared
sequences. E, EcoRI; S, SpeI, K,
KpnI. (D) Schematic representation
of membrane receptors generated
from constructs diagrammed in A,
B, and C after coinjecting the differ-
ent Hc genes with the same an-
tilysozyme  k Lc gene. 
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high-level expression of human IgG1 Tgs (26). An addi-
tional genomic fragment encompassing 
 
z
 
2.5 kb 3
 
9 
 
of the
 
g
 
M2 exon was also included to ensure presence of the 
 
gM
poly A signals. As done previously with the IgM construct
(35), the modified Hc constructs were microinjected with
the k Lc gene construct derived from the HyHEL10 hy-
bridoma. Multiple founders were obtained with each con-
struct, and breeding lines were established from each (Ta-
ble I). Different numbers of copies of the Hc and Lc Tgs
were present in each line, and these Hc and Lc genes co-
segregated in all progeny, indicating cointegration in each
of the founders.
Expression of Transgenic Receptors on Peripheral B Cells in
Transgenic Mice. Transgenic offspring from each of the
founders were analyzed by flow cytometry for the presence
of splenic B cells that expressed high-affinity lysozyme-
binding receptors encoded by pairing of the transgenic Hcs
and Lcs. B cells that stained intensely with 10 nM HEL,
which selectively identifies high-affinity cells carrying the
transgenic Hcs and Lcs (45), were present in most of the
lines, although the level of HEL-binding receptors per cell
was four- to fivefold lower on mature IgG1 cells compared
with IgM-transgenic mice (Fig. 2). As is illustrated in Fig. 2
and Table I, a much lower proportion of B cells bound
HEL in the preimmune splenic repertoire of IgG1- and
IgM/G-transgenic mice compared with the representative
IgM-transgenic mouse line, MM4. Whereas 80% of periph-
eral B cells in IgM-transgenic mice stained intensely with
lysozyme (Fig. 2, A and E), between 2 and 50% of splenic B
cells in IgG1 and IgM/G mice showed appreciable HEL
binding (Fig. 2, B, C, F, and G). The absolute number of
HEL-binding B cells in the spleen was nevertheless compa-
rable in IgM and the lower copy number IgM/G and IgG1
lines, but it was also markedly lower in high copy number
IgM/G and IgG1 lines (Table I).
Three-color staining confirmed that HEL-binding B cells
in each case expressed Tg-encoded Hcs (Fig. 2, I–L). Thus,
in the IgM/G mice, the HEL binding B cells all carried
IgM of the Tg-encoded a-allotype (IgMa; Fig. 2 J), and the
staining for IgMa on these cells was tightly correlated with
HEL binding amongst individual spleen cells, falling on a
diagonal line. Similarly, HEL-binding B cells in the IgG-
transgenic lines stained proportionally for IgG1 Hcs (Fig. 2
L). By contrast, the B cells that lacked HEL-binding recep-
tors differed between the IgG1- and IgM/G-transgenic
lines in their expression of transgenic Hc. In the IgG1-
transgenic lines, lack of HEL binding was largely due to ab-
sence of Tg-encoded IgG1 Hcs on the cell surface (Fig. 2
Table I.  Splenic B Cells with HEL-binding Receptors in Lines of IgM-, IgM/G-, and IgG1-transgenic Mice
Encoded 
receptor (line)
Tg copy 
nos.
Hc/Lc* No. of mice Mean age
No. of B 
cells/spleen
HEL-
binding 
cells/spleen‡
B cells/
spleen‡
HEL-
binding 
cells/spleen
B cells that 
bind HEL‡
wk 31027‡ %%%
Nontransgenic 0/0 11 7 6 2 6.1 6 2.8 0.2 6 0.1 34.8 6 8.0 0.2 6 0.1 0.3 6 0.1
IgM 2/2 7 12 6 4 1.4 6 1.8 1.2 6 0.3 13.4 6 3.6 11.2 6 4.0 83 6 12
IgM/G (mg6) 2/2 5 10 6 2 2.4 6 1.1 1.2 6 0.9 20.9 6 5.4 9.9 6 5.2 48 6 27
IgM/G (mg2) 3/1 13 12 6 2 1.1 6 0.5 0.5 6 0.3 15.3 6 3.7 7.3 6 2.9 47 6 10
IgM/G (mg1) 8/4 6 9 6 4 2.0 6 1.3 0.2 6 0.2 25.7 6 7.8 2.0 6 0.7 11 6 8
IgM/G (mg8A) 15/12 5 13 6 3 1.6 6 0.7 0.2 6 0.1 25.1 6 9.9 1.6 6 0.7 9 6 5
IgG1 (gg2) 2/2 2 15 6 1 6.0 6 2.2 2.5 6 0.6 32.8 6 12.3 13.7 6 3.5 42 6 5
IgG1 (gg4) 2/3 4 16 6 4 2.7 6 0.9 0.7 6 0.3 26.5 6 2.6 7.2 6 0.9 27 6 5
IgG1 (gg3) 2/3 4 17 6 7 1.8 6 0.3 0.04 6 0.03 22.3 6 4.6 0.5 6 0.3 2 6 2
IgG1 (gg1) 6/5 3 25 6 9 3.2 6 1.6 0.08 6 0.05 19.1 6 4.2 0.9 6 0.7 5 6 4
*Copy numbers estimated by densitometric scanning of autoradiographs from Southern-blotted tail DNA.
‡Determined by flow cytometry as in Fig. 2.1035 Pogue and Goodnow
Figure 2. Representative flow cytometric analysis of peripheral B cells in IgM-, IgM/G-, and IgG1-transgenic mice. (A–H) Spleen cells were stained
for high-affinity HEL binding, which depends on surface expression of receptors comprised of the transgenic Hc and Lc (y-axis), and for B220 (x-axis).
Numbers next to boxes indicate the percentages of splenocytes that were HEL-binding B lymphocytes (upper boxes) or non–HEL-binding B lympho-
cytes (lower boxes). (I–L) B2201 splenocytes from IgM (I and K), IgM/G mg2 (J), or IgG1 gg4 (L) were stained for HEL binding (y-axis) versus Tg-encoded
Hc expression (IgMa, x-axis for upper profiles; IgG1, x-axis for lower profiles). Note that in IgG1-transgenic mice, most B cells that do not bind lysozyme
lack cell surface expression of the transgenic IgG1 Hc, whereas in the IgM/G mice the non–HEL-binding cells still bear the transgenic IgMa Hc.
L). By contrast, most B cells that lacked HEL-binding re-
ceptors in the IgM/G lines still expressed the Tg-encoded
a-allotype Hc, as demonstrated by off-diagonal B cells that
stained for IgMa but not HEL (Fig. 2 J).
Endogenous Hcs were present on most non–HEL-bind-
ing B cells in IgG1 mice but not in IgM/G mice, but in
both cases, cells bearing HEL-binding receptors in these
mice appeared allelically excluded and lacked detectable en-
dogenous Hc expression. Fig. 3 shows histograms for stain-
ing of IgD on HEL-binding B cells (bold line) and non–
HEL-binding B cells (thin line) from IgM-, IgG1-, and
nontransgenic mice (upper panels) and IgM-, IgM/G-, and
nontransgenic mice (lower panels). IgD is a useful measure
of allelic exclusion because it can only be expressed if rear-
rangement of endogenous Hc genes occurs. Thus, HEL-
binding B cells from all three types of transgenic mice, IgM,
IgG1, and IgM/G, were negative for IgD expression (Fig.
3, D, E, J, and K), indicating allelic exclusion of endoge-
nous receptor expression.
Influence of Hc Tg Copy Number on Peripheral B Cell Com-
position. Analysis of multiple animals from each of the IgG1-
and IgM/G-transgenic lines revealed consistent line-to-line
differences in the proportion and number of HEL-binding
B cells in the spleen (Table I). There was a clear tendency for
these to be lowest in mice carrying more copies of the IgM/G
or IgG1 Hc Tgs. For example, in the IgM/G (mg6) line with
2 Hc copies, 48% of spleen B cells (1.2 3 107 cells) were HEL
binding, whereas in the IgM/G (mg8) line with 15 Hc copies,
9% of spleen B cells (0.2 3 107 cells) were HEL binding.
No such effect was previously observed in the set of 10 Hc-
and Lc-transgenic mice established with the IgM construct
despite a similar range of copy numbers (reference 35 and
Goodnow, C., unpublished observations). The inverse cor-
relation between copy number and number of HEL-binding
cells was not perfect, however, because one IgG1 line, gg3,
contained very few HEL-binding cells despite containing only
two copies of the Hc and three copies of the Lc Tgs (Table I).
It is conceivable that the Tgs in this mouse had integrated in a
site or way that was nonpermissive to transcription.
Loss-of-copy variant offspring from high copy lines al-
lowed the effect of copy number to be examined indepen-
dently from integration site. Flow cytometry and Southern
blot analysis revealed two separate low copy variant mice
from 32 transgenic offspring of the mg8A IgM/G line. The
parent line contained 15 copies of the Hc Tg and 12 Lc
copies (Table I), and only 6% of B cells in the blood had
HEL-binding receptors (Fig. 4, A and E). One variant off-
spring, mg8C, carried only five copies of the Hc Tg (Fig. 4
D), and the frequency of HEL-binding B cells was increased
to 52% (Fig. 4 C). Another variant, 8B, carried seven Hc
copies and three Lc copies, and the proportion of HEL-
binding B cells was increased to 18%. The 8B variant mouse
was successfully bred as a subline, and the offspring consis-
tently produced threefold higher proportions of peripheral
HEL-binding B cells than the parental line (Fig. 4 E).
A similar loss-of-copy variant was observed in one of
four transgenic offspring analyzed from the high copy gg1
IgG1 line, which contained six copies of Hc Tg and five
copies of Lc Tg. In three Tg1 gg1 offspring, ,3.6% of
spleen B cells bound lysozyme, whereas in the fourth Tg1
mouse, .14% of spleen B cells were HEL binding (not
shown). Analysis of genomic DNA from these mice by
Southern analysis revealed that the mouse with more HEL-
binding B cells had lost two copies of the Hc Tg, resulting
in four copies of Hc Tg and five copies of Lc Tg (not
shown).1036 Development of B Cells with IgG BCRs
HEL-binding IgG1 or IgM/G Receptors Are Expressed on
Most Immature B Cells, and the Levels on Early Pro-B Cells
Correlate with Tg Copy Number. In contrast to the variable
proportion of mature B cells expressing the transgenic Hcs
and Lcs in IgG1- or IgM/G-transgenic mice, the majority
of immature B cells in the bone marrow nevertheless ex-
pressed HEL-binding surface receptors (Fig. 5). Moreover,
the number of surface receptors on pro-BI B cells correlated
with Tg copy number. Fig. 5 shows representative staining
for HEL-binding receptors on the surfaces of pro-BI cells
(Hardy’s fraction A; HSAlowB220lowS71; reference 46) in
the bone marrow from IgM- and IgM/G-transgenic mice.
Whereas pro-BI cells from IgM-transgenic mice did not
express detectable HEL-binding receptors (Fig. 5 B), pro-
BI cells from IgM/G-transgenic mice with 2, 8, and 15
copies exhibited increasing levels of Tg-encoded receptors
(Fig. 5, C–E, and Table II). A similar correlation of Tg
copy number with surface expression on pro-BI cells was
observed in IgG1 lines, where IgG1 with six copies of Hc
Tg (gg1) exhibited sixfold higher levels of HEL binding
than the IgG1 line with two Tg copies (Table II).
Rescue of B Cell Maturation in RAG-22/2 Mice. The
data above indicated that large numbers of mature B cells
bearing HEL-binding IgM/G or IgG receptors could de-
velop in low copy transgenic lines, and that the majority of
these HEL-binding cells did not express detectable endog-
enous Hcs. To confirm that the IgG1 and IgM/G Hcs in
these low copy lines were indeed sufficient to provide the
signals necessary for B cell maturation in the preimmune
repertoire, representative low copy lines were crossed to
RAG-2 gene–deficient mice (47). B cells from RAG-22/2
mice are blocked in development in the bone marrow at
the c-kit1IL-2R2S7hiCD45R(B220)low  large pro-B cell
stage of development (Fig. 6, B and F) due to lack of a sig-
nal normally transmitted by the pre-B cell receptor (47,
48). As previously found with IgM/IgD-transgenic mice
(49, 50), inheritance of the anti-HEL IgM, IgG1, or IgM/G
antigen receptor Tgs was sufficient to rescue pro-B cell
Figure 3. Flow cytometric
analysis of endogenous Hc ex-
pression by HEL-binding and
non–HEL-binding B cells. Sple-
nocytes were stained for HEL
binding (lysozyme), B220, and
IgD (a combination of IgDa and
IgDb). For each spleen, HEL-
binding (upper boxed region)
and non–HEL-binding (lower
boxed region) B2201 cells were
analyzed for IgD expression,
which is displayed as a histogram
below each profile. Histograms
for HEL-binding B cells are
shown by the bold line and for
non–HEL-binding B cells by the
thin line.1037 Pogue and Goodnow
Figure 5. Expression of lysozyme-binding surface receptors on pro-BI cells is correlated with Hc Tg copy number. Bone marrow cells were analyzed
by four-color analysis for S7, HSA, B220, and lysozyme binding. In profiles A–E, S71B2201 cells were gated to display HSA and lysozyme binding.
The most immature fraction A/pro-BI cells (HSAloS71B2201) are in the boxed regions. Note that little lysozyme binding can be detected on these cells
from IgM or low copy number IgM/G mice, but this increases 10-fold in the high copy strain. No consistent differences in the frequencies of fraction
A cells in the bone marrow were noted between the different copy number lines, as the mean frequencies were: MM4, 0.91%; mg2, 1.28%; mg1,
1.20%; and mg8, 0.97%.
Figure 4. Increased numbers of HEL-binding B
cells in spontaneous copy loss variants of a high
copy IgM/G line. Two spontaneous copy loss vari-
ants were noted during Southern blot typing of
offspring from the IgM/G (mg8A) strain. (A–C)
B2201 cells in tail blood from the parental IgM/G
(mg8A) mouse line (A) and from the two variant
offspring (B and C) were stained for HEL binding
and Hc Tg (IgMa) expression. The percentage of
B2201 cells falling in the windows is shown. (D)
Southern blot analysis of SacI-digested tail DNA
from the same mice, probed with JH fragment.
The endogenous Hc germline band of 3 kb (two
copies per cell) provides an internal standard for
loading. The Hc Tg array yields many more copies
of an 11-kb fragment resulting from head–tail
junctions between copies. Smaller fragments of
variable abundance presumably result from internal
deletions and junctions with flanking DNA. (E)
Percent of B2201 cells with HEL-binding BCRs
in peripheral blood from eight offspring of the pa-
rental IgM/G line, mg8A, and from eight offspring
of the variant mouse, mg8B. Data point marked
with a single asterisk denotes variant mouse mg8C.
The mouse denoted by double asterisk was not an-
alyzed by Southern blot.
development in RAG-22/2 mice. Thus, the appearance of
S7lowB220low small B cells was restored in IgG1 RAG-22/2
bone marrow (Fig. 6, C and G, boxed areas and histo-
grams) and in IgM and IgM/G RAG-22/2 mice (not
shown).
To determine whether IgG1 antilysozyme antigen recep-
tors could also provide the signals necessary for immature B
cells to complete their development into mature circulating
B cells (51, 52), spleen and bone marrow HEL-binding B
cells were stained for expression of the mature B cell
marker CD21. Immature B cells are marked by low or
negative levels of CD21, whereas mature B cells express
medium to high levels, the latter being primarily marginal
zone B cells (53, 54). B lineage cells from nontransgenic
RAG-22/2 mice are blocked at the CD212 stage in the
bone marrow (Fig. 6 J). By contrast, B cells from IgM
RAG-22/2, IgG1 RAG-22/2, and IgM/G RAG-22/2
mice mature to the CD21low stage in the bone marrow
without any discernible difference (Fig. 6 K and data not
shown) and proceed to the CD21med and CD21high stages in
the spleen in comparable numbers (Fig. 6, Q–S). These re-
sults establish that IgG1 antigen receptors can provide the
necessary signals for B cell maturation.
Spontaneous downregulation of surface IgG1 antigen re-
ceptors compared with IgM receptors accompanied B cell
maturation in RAG-22/2 IgG1-transgenic mice, as noted
above in the RAG-21/1 background (Fig. 2). Thus, IgM
and IgG1 B cells initially carried similar surface receptor
levels at the CD212 immature B cell stage in the bone
marrow (Fig. 6, K and L). As the cells matured and in-1038 Development of B Cells with IgG BCRs
creased CD21 expression, IgM receptor levels increased
twofold (Fig. 6, L, P, and Q), whereas IgG1 receptor levels
decreased threefold (Fig. 6, K, O, and S), and IgM/G re-
ceptor levels decreased twofold (Fig. 6 R). 
Discussion
In this study, we have compared the function of a mem-
ory isotype BCR with its naive IgM counterpart during B
cell development in vivo, independent of confounding fac-
tors such as prior antigenic experience, specificity differ-
ences, and microenvironment. A well characterized
lysozyme-specific antibody combining site (32, 33) was
used to generate transgenic mice expressing IgG1 BCRs or
chimeric IgM/G receptors composed of IgM extracellular
regions and IgG1 membrane and cytoplasmic regions. The
data show that IgG1 antigen receptors can substitute for
IgM in supporting B cell allelic exclusion, development,
and maturation in the preimmune repertoire. Thus, large
numbers of IgG1 or IgM/G Tg receptor–expressing B cells
were present in the periphery, and these cells did not coex-
press endogenous IgM or IgD receptors. Several features of
B cell development nevertheless differed markedly in
IgG1- and IgM/G-transgenic mice compared with IgM-
transgenic animals, indicating that functional differences
between these isotypes do exist and are due at least in part
to the unique IgG transmembrane region and cytoplasmic
tail.
IgG1 Antigen Receptor Transmits Signals Required for B Cell
Development and Allelic Exclusion. The absolute require-
ment for membrane m to signal the transition from the pro-B
to pre-B cell stage and to cease further Hc gene rearrange-
ment was demonstrated in recent years using mutant mice
generated by targeted disruption of genes involved in ex-
pression or signaling of m Hc (47, 55–59). In all of these
mice, development was blocked at the pro-B cell/large
pre-B cell stage, with few small pre-B cells or immature B
cells detected in the bone marrow. Given the structural dif-
ferences in the IgM and IgG membrane-proximal regions, it
has been suggested that the IgG Hc may not be able to pro-
vide the necessary signals for pro-B to B cell transition (27,
29) and allelic exclusion (23, 24, 26). The findings here
demonstrate that IgG1 can transmit the signals for allelic ex-
clusion and B cell maturation, but this is complicated in
mice with supraphysiological gene dosage. Thus, expression
of IgG1 antigen receptor in low copy transgenic mice res-
cued B cell maturation in RAG-22/2 mice, as demonstrated
by appearance of S7lowB220low small B cells in bone marrow
and production of mature CD211 B cells in the periphery.
Secondly, analysis of surface receptor isotypes expressed on
mature B cells of IgG1 mice did not reveal a significant
population of cells coexpressing endogenous receptors with
IgG1 receptors, demonstrating that IgG1 can mediate allelic
exclusion.
Sensitivity of IgG B Cell Maturation to Excessive Tg Copy
Number. Unlike IgM anti-HEL transgenic mice, where
typically more than 80% of peripheral B cells bound HEL
and carried the transgenic receptor, less than half of periph-
eral B cells from IgG1 or IgM/G low copy number mice
bound HEL. This phenotype was further exaggerated in
mice with higher Hc Tg copy numbers, such that in IgM/G
mice containing 15 Hc gene copies, ,9% of B cells bound
HEL. In IgG-transgenic mice that contained six copies of
Hc, only 3% of splenic B cells bound HEL. The lower fre-
quency of Tg-expressing B cells was specific to mice ex-
pressing the g1 transmembrane and cytoplasmic tail, as it has
not been observed in other transgenic mice carrying HEL-
binding IgM, IgD, or chimeric IgM/D receptors containing
the IgD transmembrane and cytoplasmic regions (reference
35 and Pogue, S.L., and C.C. Goodnow, unpublished ob-
servations). FACS® analysis of the non–HEL-binding B cells
in the IgG1- or IgM/G-transgenic mice revealed that they
carried antigen receptors containing endogenous Hc or
transgenic Hc presumably paired with endogenous Lc.
Table II. Mean Fluorescence of HEL-binding Receptor Levels in IgM/G Pro-B Cells and IgG1 Pro-B Cells
Tg line Tg copy no. Analysis 1 Analysis 2 Analysis 3 Analysis 4 Analysis 5 Analysis 6 Mean 6 SD
IgM 2 0.15 0.15 0.15 0.15 – 2.0 0.5 6 0.8
IgM/G mg2 3 1.8 2.0 3.0 1.5 4.0 3.5 2.6 6 1.0
IgM/G mg1 8 8.0 6.0 8.0 7.0 15.0 15.0 10.4 6 4.3
IgM/G mg8 15 – 15.0 – 25.0 25.0 30.0 23.8 6 6.3
IgM 2 0.15 0.15 –––– 0.15 6 0.8
IgG1 gg4 2 0.5 0.6, 0.5, 0.5 –––– 0.5 6 0.1
IgG1 gg1 6 4.0 3.5, 3.0, 1.5 –––– 3.0 6 1.1
Bone marrow cells were stained as in Fig. 5. Mean fluorescence levels of HEL-binding receptors on pro-B1 (B2201S71HSAlow) cells from six
(IgM/G) and two (IgG1) separate FACS® analyses were tabulated.1039 Pogue and Goodnow
The appearance of large numbers of B cells bearing en-
dogenous receptors does not reflect failure of the IgG or
IgM/G receptors to trigger allelic exclusion in either the
low or high copy lines. Thus, those B cells that carried
HEL-binding receptors did not carry endogenous Hcs (Fig.
4), and B cells with endogenous receptors lacked transgenic
HEL-binding IgG (Fig. 3 B). Moreover, B cells that bore
exclusively transgenic receptors were fully mature even in
high copy lines, indicating that the receptor was in each
case able to support the preimmune phase of maturation to
varying degrees. Instead, the IgG1 and IgM/G Tgs appear
to favor accumulation of “edited” B cells that have lost
transgenic Hc or Lc expression and gained expression of
endogenous Hc or Lc, especially in higher copy lines. This
loss must occur at or before the developmental stage in
which RAG expression occurs, thereby allowing rear-
rangement of endogenous Hc. It is not known whether loss
of Tg expression reflects deletion of the Tg DNA, suppres-
sion of transcription, or competitive protein assembly and
transport to the cell surface.
Figure 6. Tg-encoded IgG1
antigen receptors rescue bone
marrow B cell development and
B maturation in RAG-22/2
mice. (a–h) Bone marrow cells
from nontransgenic, RAG-21/2
(a and e), nontransgenic, RAG-
22/2 (b and f), IgG1-transgenic,
RAG-22/2 (c and g), or IgM-
transgenic, RAG-21/1 mice (d
and h) were stained with anti-
CD43 (S7) and anti-CD45
(B220) antibody and analyzed by
flow cytometry. Boxed cells in
a–d were gated to yield forward
scatter histograms in e–h as a
measure of cell size (bold lines).
For reference, the thin line in
each display is the histogram of
the S7lowB220low nontransgenic
RAG-22/2 pro-B cell popula-
tion. Numbers represent per-
centage of bone marrow cells
falling within boxed region. (i–p)
Bone marrow (i–l) and spleen
cells (m–p) of the same mice
were stained for B220, HEL
binding, and CD21. Profiles
show gated B2201 cells, and the
percentage of bone marrow or
spleen cells falling within the
CD211 mature B cell window is
indicated. (q–s) Comparison of
CD21 expression and HEL-
binding receptors on B2201 cells
in the spleens of RAG-22/2
mice carrying the IgM, IgM/G,
or IgG BCR Tgs.1040 Development of B Cells with IgG BCRs
The sensitivity to gene dose observed here may explain
the variability among IgG-expressing transgenic mouse
strains reported previously (23–30). One of the most ex-
tensive analyses of IgG-expressing transgenic mice was
conducted in the laboratory of Roth and coworkers (27,
29) and by Kenny et al. (28). In transgenic mice from two
of these lines, 343-1 and 348A, carrying 8–16 or 22–60 sta-
bly integrated copies of the Hc Tg, respectively, the num-
ber of splenic B cells was 10–30% of normal. The mature B
cells that were present in these mice expressed high levels
of IgM receptors derived from endogenous gene rearrange-
ments and carried only low levels of the transgenic IgG2b
on their cell surfaces (27–29, 60). When the 343-1 line was
crossed with mice homozygous for a targeted disruption of
the IgM membrane exons, few mature B cells developed,
indicating that the g2b Hc did not allow maturation or ac-
cumulation of preimmune cells in the absence of mem-
brane IgM. By contrast, almost normal numbers of splenic
B cells developed bearing exclusively the transgenic IgG2b
receptors in a third line with the same IgG2b Hc gene,
348C (28, 29). Unlike the 343-1 and 348A mice, the 348C
line carried only three copies of the Tg and was derived
from an unstable line, 348-4-8 (348B), carrying 90 Tg cop-
ies (60). The conclusion favored at the time was that IgG is
intrinsically unable to signal for B cell maturation normally,
but this defect was somehow complemented by an integra-
tion site effect in the 348C variant line.
The evidence that IgG cannot signal for B cell matura-
tion is supported by data similar to that from the 343-1
line, obtained in mice carrying an undetermined number of
copies of an IgG2a/k Tg encoding an anti-CD8.2 antibody
(30). In these mice, surface IgM expression was inhibited in
the bone marrow, but the number of mature splenic B cells
was 15% of normal, and these expressed high levels of en-
dogenous IgM and IgD and lower levels of IgG2a.
By contrast, IgG did support maturation of small num-
bers of B cells in the absence of endogenous IgM in an an-
tiphosphorylcholine IgG2b/k transgenic line carrying an
unspecified number of Tg copies (28). The recovery of B
cell maturation in several independent copy loss variants
from high copy number lines observed here appears similar
to the history of the copy loss variant 348C line described
by Roth et al. (29). Loss of Tg copies is likely to result
from intrachromosomal recombination within the Tg array
before or during meiosis, as postulated for copy reduction
variants arising among somatic cells (61, 62).
Possible Signaling Differences Conferred by the IgG Mem-
brane and Cytoplasmic Domains. The varied numbers and
frequency of HEL-binding mature B cells in IgG1- or
IgM/G-transgenic mice could reflect either too little of a
BCR signal needed for cell maturation or too much of a
BCR signal that inhibits maturation. BCR signaling by
IgM (or IgD) is required by preimmune B cells, first to
trigger allelic exclusion and B cell maturation in the bone
marrow and then to promote survival and accumulation in
the spleen, lymph nodes, and blood (48, 51, 63). The na-
ture of these intracellular positive signals is unclear, al-
though the tyrosine kinase Syk is required for maturation
in the bone marrow (58, 59), and the tyrosine kinase Btk
and the src-activating tyrosine phosphatase CD45 are re-
quired for survival and accumulation of mature cells in the
spleen (51, 64). If these positive signals were not suffi-
ciently activated by BCRs with the IgG transmembrane
and cytoplasmic regions, that could in principle favor mat-
uration of B cells that had lost the Tg and replaced it with
an endogenous IgM/IgD receptor or non–HEL-binding
IgM/G receptor, as observed in the IgG and IgM/G mice,
respectively. Other data makes this interpretation less
likely: (a) a comparable preferential accumulation of vari-
ant B cells is not observed in anti-HEL IgM/IgD-trans-
genic mice when positive selection signals are crippled by
mutations in Btk or CD45; and (b) spontaneous downreg-
ulation of IgM BCRs on mature B cells, as occurs during
maturation of IgG and IgM/G cells, does not occur but is
in fact suppressed when positive selection signals are crip-
pled (51, 64, and Goodnow, C., unpublished data).
We believe the alternative interpretation, namely exag-
gerated signaling by IgG and IgM/G BCRs, represents a
better explanation for the data. Maturation and accumula-
tion of IgM- or IgD-bearing B cells is inhibited by chronic
activation of inhibitory signals triggered either by self-anti-
gen binding (53, 65–67) or by exaggeration of basal or
antigen-induced BCR signaling in the absence of the in-
hibitory tyrosine phosphatase, Src homology 2 domain–
containing protein tyrosine phosphatase (SHP)-1 (54).
This promotes the formation of edited B cells that have
lost or reduced expression of the transgenic Hc or Lc genes
and replaced them by an endogenously encoded Hc or Lc
(62, 68–71). Interestingly, Lc gene editing predominates in
anti-DNA IgM-transgenic mice with weakly DNA-reac-
tive BCRs, whereas Hc editing predominated in anti-
DNA transgenic mice with V region substitutions that
conferred stronger DNA reactivity (62, 69, 70). It is inter-
esting that the variant B cells accumulating in the spleens
of IgG-transgenic mice have primarily lost the transgenic
Hc, whereas the variant cells accumulating in the spleens
of IgM/G mice retain the transgenic Hc and lose HEL
binding, presumably due to loss of the transgenic Lc (Fig.
3). Based on the above, we hypothesize that IgG has an
enhanced ability to trigger signals that inhibit immature B
cell maturation when compared with IgM, and that the
IgM/G chimera has the same characteristic but to a lesser
degree. In the lines of IgG- and IgM/G-transgenic mice
with supraphysiological gene dosage, higher amounts of
BCR protein are made, as judged by surface staining of
pro-B cells (Fig. 5 and Table II). The fact that fewer B cells
mature with the transgenic receptor and more develop
with the edited phenotype in these high copy lines is con-
sistent with a further exaggeration of signals that inhibit
maturation as a consequence of overexpressed IgG and
IgM/G receptors.
The notion that IgG and IgM/G have exaggerated sig-
naling is also consistent with the spontaneous downregula-
tion of these receptors on mature B cells (Fig. 6). Similar
decreases in surface display of IgMHEL receptors occurs dur-
ing progression from immature to mature B cells in re-1041 Pogue and Goodnow
sponse to chronic BCR signaling. This can occur as a result
of continuous binding of soluble HEL autoantigen (34), in
which case chronic signaling and downregulation is sup-
pressed in the absence of the stimulatory tyrosine phos-
phatase CD45 (51, 67). IgM receptors also downregulate
spontaneously when BCR signaling is exaggerated by lack
of the inhibitory phosphatase SHP-1 (54), absence of
CD22, which recruits SHP-1 to the BCR signaling com-
plex (72–75), or overexpression of CD19, which augments
BCR signaling (76). It is interesting that spontaneous
downregulation of BCRs on mature B cells is more ex-
treme for IgG than for IgM/G, in line with the more ex-
treme editing that occurs in the IgG mice (above).
The decreased surface expression of IgG BCRs observed
here on mature B cells matches a characteristic of isotype-
switched memory B cells in vivo (77). Hayakawa et al.
found that isotype-switched memory B cells in the spleens
of immunized mice had four- to fivefold fewer k chains on
the cell surface compared with naive IgM1IgD1 B cells in
the same animals. It is interesting that, without immuniza-
tion, the IgG and IgM/G B cells also tend to accumulate in
the CD21high marginal zone subset in the spleen (Fig. 6), as
this subset contains many of the memory B cells in immu-
nized animals (78–80). The low copy number transgenic
mouse lines described here make possible future studies to
explore the function of switched BCR isotypes in later
phases of B cell development, particularly during B cell ac-
tivation and differentiation into plasma cells and memory
cells.
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